Policy changes and digital strategies guide oncology research
Against the backdrop of the recent US Food and Drug Administration’s (FDA) staff cuts and administrative realignment, understanding accelerated approval…
Features
Introducing the Clinical Trials Arena Excellence Awards 2025
Psychedelic drug developers redesign trials to avoid Lykos faux pas
Patient-centric trials: progress but gaps remain
Power of collaboration more pertinent than ever says pharma experts
Pharma’s AI prospects get nudged into the future with EU’s AI act
Are regulators keeping pace with AI adoption in clinical trials?
How can pharma manage rising trial costs?
